Author:
Gupta Shilpa,Moon Helen H.-S.,Sridhar Srikala S.
Publisher
Springer Science and Business Media LLC
Reference77 articles.
1. American Cancer Society. Survival Rates for Bladder Cancer. https://www.cancer.org/cancer/bladder-cancer/detection-diagnosis-staging/survival-rates.html. Accessed 5 Apr 2024.
2. NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer. V2.2024.
3. Cathomas R, Lorch A, Bruins HM, et al. The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma. Eur Urol. 2021;81(1):95–103.
4. Powles T, Bellmunt J, Comperat E, et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(3):244–58.
5. Powles T, Valderrama BP, Gupta S, et al. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. N Engl J Med. 2024;390(10):875–88.